There are 2 versions of this amendment. View text

Jump to: Purpose | Actions | Cosponsors

Purpose

To clarify the authority of the Office of Surveillance and Epidemiology with respect to postmarket drug safety pursuant to recommendations by the Institute of Medicine.


Actions (3)

Date All Actions
05/09/2007Amendment SA 1039 not agreed to in Senate by Yea-Nay Vote. 46 - 47. Record Vote Number: 154.
05/09/2007Considered by Senate. (consideration: CR S5759, S5768-5769, S5771-5772)
05/08/2007Amendment SA 1039 proposed by Senator Brown for Senator Grassley. (consideration: CR S5705-5706; text: CR S5705) To clarify the authority of the Office of Surveillance and Epidemiology with respect to postmarket drug safety pursuant to recommendations by the Institute of Medicine.

Cosponsors (4)

* = Original cosponsor
Cosponsor Date Cosponsored
Sen. Mikulski, Barbara A. [D-MD] 05/09/2007
Sen. Brown, Sherrod [D-OH] 05/09/2007
Sen. Snowe, Olympia J. [R-ME] 05/09/2007
Sen. Bingaman, Jeff [D-NM] 05/09/2007